Alnylam Pharmaceuticals Inc (ALNY)
143.82
-2.24
(-1.53%)
USD |
NASDAQ |
Apr 24, 16:00
143.82
0.00 (0.00%)
After-Hours: 18:40
Alnylam Pharmaceuticals Accounts Payable (Quarterly): 55.52M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 55.52M |
September 30, 2023 | 73.84M |
June 30, 2023 | 59.75M |
March 31, 2023 | 62.24M |
December 31, 2022 | 98.09M |
September 30, 2022 | 40.57M |
June 30, 2022 | 52.42M |
March 31, 2022 | 54.92M |
December 31, 2021 | 73.43M |
September 30, 2021 | 40.05M |
June 30, 2021 | 53.08M |
March 31, 2021 | 45.38M |
December 31, 2020 | 51.97M |
September 30, 2020 | 27.87M |
June 30, 2020 | 26.12M |
March 31, 2020 | 40.48M |
December 31, 2019 | 49.88M |
September 30, 2019 | 39.39M |
June 30, 2019 | 71.22M |
March 31, 2019 | 22.67M |
December 31, 2018 | 59.71M |
September 30, 2018 | 21.77M |
June 30, 2018 | 11.99M |
March 31, 2018 | 13.21M |
December 31, 2017 | 28.36M |
Date | Value |
---|---|
September 30, 2017 | 9.239M |
June 30, 2017 | 23.17M |
March 31, 2017 | 25.37M |
December 31, 2016 | 54.46M |
September 30, 2016 | 23.14M |
June 30, 2016 | 12.82M |
March 31, 2016 | 17.44M |
December 31, 2015 | 16.79M |
September 30, 2015 | 14.27M |
June 30, 2015 | 15.72M |
March 31, 2015 | 15.49M |
December 31, 2014 | 15.11M |
September 30, 2014 | 5.201M |
June 30, 2014 | 6.168M |
March 31, 2014 | 5.037M |
December 31, 2013 | 5.896M |
September 30, 2013 | 2.728M |
June 30, 2013 | 4.534M |
March 31, 2013 | 3.105M |
December 31, 2012 | 4.42M |
September 30, 2012 | 5.093M |
June 30, 2012 | 5.519M |
March 31, 2012 | 4.339M |
December 31, 2011 | 5.80M |
September 30, 2011 | 5.486M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
26.12M
Minimum
Jun 2020
98.09M
Maximum
Dec 2022
53.48M
Average
52.42M
Median
Jun 2022
Accounts Payable (Quarterly) Benchmarks
Ionis Pharmaceuticals Inc | 26.03M |
Pfizer Inc | 6.71B |
Blueprint Medicines Corp | 4.71M |
Madrigal Pharmaceuticals Inc | 28.04M |
Sarepta Therapeutics Inc | 164.92M |